中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

乙型肝炎相关慢加急性肝衰竭患者血清白细胞介素1受体拮抗剂与疾病严重程度的关系

赖静兰 刘玉明 林春 孙芳 周锐 林勇 林元豹

引用本文:
Citation:

乙型肝炎相关慢加急性肝衰竭患者血清白细胞介素1受体拮抗剂与疾病严重程度的关系

DOI: 10.3969/j.issn.1001-5256.2016.05.015
基金项目: 

福州市科技计划项目(2013-S-125-3); 福建省卫生与计划生育委员会青年科研基金项目(2013-2-82); 福建省青年教师教育项目(JB13126); 福建省卫计委青年科研基金项目(2013-2-81); 

详细信息
  • 中图分类号: R512.62;R575.3

Correlation between serum interleukin-1 receptor antagonist and disease severity in patients with HBV-related liver failure

Research funding: 

 

  • 摘要:

    目的探讨乙型肝炎相关慢加急性肝衰竭(HBV-ACLF)患者外周血白细胞介素(IL)1受体拮抗剂(IL-1Ra)与患者疾病严重程度的关系。方法选取福州市传染病医院2013年10月-2015年1月就诊的31例HBV-ACLF患者为研究对象,另选取同期28例急性乙型肝炎(AHB)和30例慢性乙型肝炎(CHB)患者作为对照。用Q-Plex法检测外周血IL-1Ra、IL-1β、IL-6、IL-4、IL-10、肿瘤坏死因子(TNF)α、干扰素(IFN)γ等细胞因子浓度,并检测各组肝功能、凝血功能等,将血清IL-1Ra等细胞因子浓度与患者肝功能、MELD评分及HBV DNA等进行相关分析。多组间比较采用Kruskal-wallis H检验,进一步两两比较采用Mann-Whitney U检验;计数资料采用χ2检验;相关分析采用Spearman秩相关。结果 IL-1Ra、IL-1Ra/IL-1β在3组之间的差异均有统计学意义(P值均<0.05),其中HBV-ACLF组IL-1Ra水平[186.46(162.68512.90)pg/ml]显著高于CHB组[70.47(47.07...

     

  • [1]JALAN R,YURDAYDIN C,BAJAJ JS,et al.Toward an improved definition of acute-on-chronic liver failure[J].Gastroenterology,2014,147(1):4-10.
    [2]LIU H,CHEN G,GAN XM.Research advances in new approaches to treatment of acute-on-chronic liver failure[J].J Clin Hepatol,2015,31(9):1496-1500.(in Chinese).刘洪,陈刚,甘雪梅.慢加急性肝衰竭治疗的新技术及其研究进展[J].临床肝胆病杂志,2015,31(9):1496-1500.
    [3]LIU Q.Role of cytokines in the pathophysiology of acute-on-chronic liver failure[J].Blood Purification,2009,28(4):331-341.
    [4]SARIN SK,KEDARISETTY CK,ABBAS Z,et al.Acute-on-chronic liver failure:consensus recommendations of the Asian Pacific Association for the Study of the Liver(APASL)2014[J].Hepatol Int,2014,8(4):453-471.
    [5]National Clinical Guideline Centre(UK).Hepatitis B(chronic):diagnosis and management of chronic hepatitis b in children,young people and adults[EB/OL].NICE Clinical Guidelines(No 165)[2013-06].http://www.ncbi.nlm.nih.gov/pubmed/25473721
    [6]WANG DW,YIN YM,YAO YM.Advances in the management of acute liver failure[J].World J Gastroenterol,2013,19(41):7069-7077.
    [7]BODE JG,ALBRECHT U,HAUSSINGER D,et al.Hepatic acute phase proteins—regulation by IL-6-and IL-1-type cytokines involving STAT3 and its crosstalk with NF-kappaB-dependent signaling[J].Eur J Cell Biol,2012,91(6-7):496-505.
    [8]SHI XL,ZHU W,TAN JJ,et al.Effect evaluation of interleukin-1 receptor antagonist nanoparticles for mesenchymal stem cell transplantation[J].World J Gastroenterol,2013,19(12):1984-1991.
    [9]MOLL M,KUEMMERLE-DESCHNER JB.Inflammasome and cytokine blocking strategies in autoinflammatory disorders[J].Clin Immunol,2013,147(3):242-275.
    [10]HOPE S,UELAND T,STEEN NE,et al.Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder[J].Schizophrenia research,2013,145(1-3):36-42.
    [11]ZHENG YB,ZHANG XH,HUANG ZL,et al.Amniotic-fluid-derived mesenchymal stem cells overexpressing interleukin-1 receptor antagonist improve fulminant hepatic failure[J].PLoS One,2012,7(7):e41392.
    [12]SGROI A,GONELLE-GISPERT C,MOREL P,et al.Interleukin-1 receptor antagonist modulates the early phase of liver regeneration after partial hepatectomy in mice[J].PLoS One,2011,6(9):e25442.
    [13]DINARELLO CA.Immunological and inflammatory functions of the interleukin-1 family[J].Annu Rev Immunol,2009,27:519-550.
    [14]HU J,YAN D,GAO J,et al.rh IL-1Ra reduces hepatocellular apoptosis in mice with acetaminophen-induced acute liver failure[J].Lab Invest,2010,90(12):1737-1746.
  • 加载中
计量
  • 文章访问数:  2140
  • HTML全文浏览量:  40
  • PDF下载量:  458
  • 被引次数: 0
出版历程
  • 出版日期:  2016-05-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回